In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
Eye movement reaction time, speed and accuracy are impaired when a middle-aged person or older adult drinks, even if that person drinks excessively and has a “tolerance” to drinking alcohol, a new ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results